1,200 articles
Kohei Miyazono
Kohei Miyazono (宮園浩平, born 1956) is a Japanese cancer biologist known for work on TGF-β signaling, the tumor microenvironment, and metastasis, and is Distinguished University Professor at the University of Tokyo.
Kohei Shitara
Kohei Shitara (設樂 紘平) is a Japanese medical oncologist who directs gastrointestinal oncology at the National Cancer Center Hospital East and led the DESTINY-Gastric01 and SPOTLIGHT trials.
Komal Jhaveri
Komal Jhaveri is a breast medical oncologist at Memorial Sloan Kettering Cancer Center, where she heads the Endocrine Therapy Research Program and led the INAVO120 and EMBER-3 trials.
Kornélia Polyák
Kornélia Polyák (Kornelia Polyak) is a Hungarian-born physician-scientist, Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, known for cloning p27Kip1 in 1994 and for research on breast tumor evolution and heterogeneity.
Kristian Helin
Kristian Helin is a Danish cancer researcher working on epigenetics who has led the Institute of Cancer Research in London since 2021 and identified the first E2F transcription factors.
Kurt Straíf
Kurt Straif is a German-trained cancer epidemiologist and physician who headed the IARC Monographs Program in Lyon and joined Boston College as a Research Professor in 2022.
Kwok-Kin Wong
Kwok-Kin Wong is a medical oncologist and cancer biologist who directs hematology and medical oncology at NYU Langone and studies lung cancer through genetically engineered mouse models.
Larry E. Kun
Larry E. Kun (1946–2018) was an American pediatric radiation oncologist who built St. Jude's brain tumor program and led trials delaying radiation for young children.
Larry Norton
Larry Norton is an American medical oncologist at Memorial Sloan Kettering Cancer Center, known for the Norton–Simon model of tumor growth, dose-dense chemotherapy, and HER2-directed breast cancer therapy.
Larry W. Kwak
Larry W. Kwak is an American hematologist-oncologist and cancer vaccine researcher who developed one of the first personalized therapeutic cancer vaccines, for B-cell lymphoma, and was named to the TIME 100 in 2010.
Lars Holmberg
Lars Holmberg is a Swedish cancer epidemiologist and oncology researcher, Professor Emeritus at King's College London and Uppsala University, best known for the SPCG-4 trial of prostatectomy versus watchful waiting.
Lars Zender
Lars Zender (born 1975 in Hanover) is a German medical oncologist at University Hospital Tübingen known for in vivo RNAi screens in living mouse livers and for first-in-class MKK4 inhibitor drugs.
Laura D. Attardi
Laura D. Attardi is an American cancer geneticist at Stanford University who studies the p53 tumor suppressor and is a member of the National Academy of Sciences.
Laura J. Esserman
Laura J. Esserman is an American surgeon and breast cancer researcher at UCSF who has directed its Breast Care Center since 1996 and leads the I-SPY 2 trial.
Laura Pasqualucci
Laura Pasqualucci is an Italian cancer geneticist who identified KMT2D and CREBBP as tumor suppressors in B cell lymphomas, and directs a Lymphomagenesis Laboratory in Bellinzona, Switzerland.
Laurence Zitvogel
Laurence Zitvogel is a French clinical oncologist and immunologist, professor at Université Paris-Saclay, known for immunogenic cell death and how gut microbiota shape cancer immunotherapy response.
Lauri A. Aaltonen
Lauri A. Aaltonen is a Finnish physician-scientist, Professor of Tumor Genomics at the University of Helsinki, known for establishing the molecular basis of hereditary colorectal cancer.
Laurie H. Sehn
Laurie H. Sehn is a Canadian medical oncologist and lymphoma researcher in Vancouver who developed the revised International Prognostic Index and led trials of new lymphoma treatments.
Lawrence Fong
Lawrence Fong is a physician-scientist in cancer immunotherapy who treats prostate, bladder, and kidney cancers and directs the Immunotherapy Integrated Research Center at Fred Hutchinson Cancer Center, after founding UCSF's Cancer Immunotherapy Program.
Lawrence H. Einhorn
Lawrence H. Einhorn is an American medical oncologist at the Indiana University School of Medicine who developed the cisplatin-based chemotherapy regimens that made metastatic testicular cancer highly curable.
Lecia V. Sequist
Lecia V. Sequist is an American medical oncologist and lung cancer researcher who is a professor at Harvard Medical School and practices at Massachusetts General Hospital.
Lee M. Ellis
Lee M. Ellis is an American surgical oncologist and cancer researcher at MD Anderson known for angiogenesis research in colorectal cancer and a 2012 Nature commentary on reproducibility.
Lee M. Nadler
Lee M. Nadler, also known as Lee Nadler, is an American physician-scientist in cancer immunology at Dana-Farber and Harvard Medical School whose laboratory discovered CD19 and CD20, leading to Rituxan.
Lee W. Jones
Lee W. Jones is a Canadian-born exercise oncology researcher who quantified how chemotherapy degrades fitness and ran randomized trials of prescribed exercise therapy at Duke and Memorial Sloan Kettering.
Leo Loeb
Leo Loeb (1869–1959) was a German-born American pathologist who pioneered experimental cancer research in the United States, showing that hormones could bring about cancerous transformation.
Leo Sachs
Leo Sachs (Hebrew: לאו זקס; 1924–2013) was a German-born Israeli molecular biologist who founded the Department of Genetics at the Weizmann Institute and discovered colony-stimulating factors.
Leonard B. Saltz
Leonard B. Saltz, also known as Leonard Saltz, is an American medical oncologist at Memorial Sloan Kettering who specializes in gastrointestinal cancers, especially colorectal cancer.
Lesley Seymour
Lesley Seymour is a Canadian medical oncologist who directs the Canadian Cancer Trials Group's Investigational New Drug Program in Kingston, Ontario, specializing in lung cancer.
Leslie L. Robison
Leslie L. Robison is an American cancer epidemiologist who chaired the Department of Epidemiology and Cancer Control at St. Jude Children's Research Hospital in Memphis and led the Childhood Cancer Survivor Study.
Lewis A. Chodosh
Lewis A. Chodosh is an American physician-scientist and breast cancer researcher who chairs the Department of Cancer Biology at the University of Pennsylvania's Perelman School of Medicine.